 TORRANCE, Calif., Jan. 4, 2022 PRNewswire -- Emmaus Life Sciences, Inc. OTCQX: EMMA, a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced that Yutaka Niihara, M.D. 